Inventor · disambiguated record
Roy Levitt
Also filed as: LEVITT JR ROY C · LEVITT ROY · LEVITT ROY C · LEVITT ROY CLIFFORD
28 granted patents·13 pending applications·331 citations·filing 1992–2024
97Inventor score
Top patents by PatentIndex Score
41 records- 0196US5908839AAsthma associated factors as targets for treating atopic allergies including asthma and related disordersMAGAININ PHARMA·Filed 1996·Granted Jun 1, 1999·107 cites·4 claims
- 0294US7700088B2Interleukin-9 mutein peptidesGENAERA CORP·Filed 2007·Granted Apr 20, 2010·17 cites·16 claims
- 0390US8940683B2Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsLEVITT ROY C·Filed 2007·Granted Jan 27, 2015·14 cites·8 claims
- 0488US7192578B2Interleukin-9 mutein peptidesGENAERA CORP·Filed 2003·Granted Mar 20, 2007·17 cites·12 claims
- 0587US11091763B2Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsALTAVANT SCIENCES GMBH·Filed 2019·Granted Aug 17, 2021·1 cites·20 claims
- 0687US8637469B2Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitorsLEVITT ROY CLIFFORD·Filed 2007·Granted Jan 28, 2014·15 cites·16 claims
- 0787US6261559B1Methods of treating asthma with interleukin-9 antibodiesGENAERA CORP·Filed 1999·Granted Jul 17, 2001·42 cites·17 claims
- 0886US7345051B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2002·Granted Mar 18, 2008·30 cites·27 claims
- 0984US6737427B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2001·Granted May 18, 2004·19 cites·59 claims
- 1083US10550389B2Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsLEVITT ROY C·Filed 2015·Granted Feb 4, 2020·3 cites·29 claims
- 1181US6645492B2Methods of treating asthma with interleukin-9 receptor antibodiesGENAERA CORP·Filed 2001·Granted Nov 11, 2003·8 cites·17 claims
- 1280US7981876B2Polymorphic and amorphous salt forms of squalamine dilactateOHR PHARMACEUTICALS INC·Filed 2006·Granted Jul 19, 2011·10 cites·12 claims
- 1379US2024084306A1Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsONSPIRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1477US7504409B2Mucin synthesis inhibitorsGENAERA CORP·Filed 2004·Granted Mar 17, 2009·9 cites·58 claims
- 1573US11718853B2Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsONSPIRA THERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·0 cites·26 claims
- 1673US7056698B2Nucleic acids encoding interleukin-9 receptor variantsGENAERA CORP·Filed 2002·Granted Jun 6, 2006·1 cites·13 claims
- 1773US6602850B1Method of treating asthma using soluble IL-9 receptor variantsGENAERA CORP·Filed 2000·Granted Aug 5, 2003·1 cites·27 claims
- 1872US7074778B2Asthma associated factors as targets for treating atopic allergies including asthma and related disordersGENAERA CORP·Filed 2000·Granted Jul 11, 2006·5 cites·7 claims
- 1969US6716603B2Nucleic acids encoding a chloride channel proteinGENAERA CORP·Filed 2002·Granted Apr 6, 2004·3 cites·18 claims
- 2069US2024366736A1Method for managing painUNIV MIAMI·Filed 2024·Application pending·0 cites
- 2167US7704710B2Interleukin-9 receptor mutantsGENAERA CORP·Filed 2008·Granted Apr 27, 2010·0 cites·18 claims
- 2267US7208292B2Nucleic acid encoding an interleukin-9 receptor variantGENAERA CORP·Filed 2006·Granted Apr 24, 2007·0 cites·10 claims
- 2365US6037149ADNA encoding human asthma associated factor 1MAGAININ PHARMA·Filed 1996·Granted Mar 14, 2000·12 cites·23 claims
- 2463US7384767B2Nucleic acid encoding an interleukin-9 receptor variantGENAERA CORP·Filed 2007·Granted Jun 10, 2008·0 cites·18 claims
- 2562US7919248B2Methods for the modulation of IL-13LIGAND PHARM INC·Filed 2008·Granted Apr 5, 2011·0 cites·12 claims
- 2659US8716270B2Polymorphic and amorphous salt forms of squalamine dilactateCHELLQUIST ERIC·Filed 2011·Granted May 6, 2014·1 cites·4 claims
- 2759US2009068185A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersHOLROYD KENNETH J·Filed 2007·Application pending·0 cites
- 2858US2011224406A1Interleukin-9 receptor mutantsLEVITT ROY CLIFFORD·Filed 2010·Application pending·0 cites
- 2957US11911450B2Method for managing painUNIV MIAMI·Filed 2018·Granted Feb 27, 2024·0 cites·23 claims
- 3056US7211254B2Methods for treating ICACC protein associated diseasesGENAERA CORP·Filed 2004·Granted May 1, 2007·0 cites·12 claims
- 3156US6576434B1Methods for identification of agents which modulate chloride channel activityGENAERA CORP·Filed 1999·Granted Jun 10, 2003·10 cites·32 claims
- 3252US2011224153A1Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related DisordersLEVITT ROY CLIFFORD·Filed 2010·Application pending·0 cites
- 3352US2007088003A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersGENAERA CORP·Filed 2006·Application pending·0 cites
- 3451US2014311482A1Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine InhibitorsLEVITT ROY C·Filed 2014·Application pending·0 cites
- 3546US2002165244A1Mucin synthesis inhibitorsFiled 2001·Application pending·0 cites
- 3646US2002147216A1Mucin synthesis inhibitorsFiled 2001·Application pending·0 cites
- 3745US2008096981A1Antibodies against inducible TH2 cell factorsGENAERA CORP·Filed 2006·Application pending·0 cites
- 3843US2005249675A1Mucin synthesis inhibitorsHUNG HSIAO-LING·Filed 2004·Application pending·0 cites
- 3942US2003166150A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 4040US5384462AProcess and apparatus for localizing a source of charged particles using an electric fieldFiled 1992·Granted Jan 24, 1995·6 cites·7 claims
- 4140US2002156013A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →